ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
126.922,11
-0,99%
S&P 500
5.948,71
0,53%
US Dollar vs BRL
5,814
-0,03%
Bitcoin
99.094,30
0,60%
Brent Oil
74,375
0,60%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. NanoVibronix Inc (NAOV)

  7. NanoVibronix Inc (NAOV) Notícias

NAOV

NanoVibronix (NAOV)

NanoVibronix Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NAOV
DataHoraFonteTítuloCódigoCompanhia
14/11/202419:17Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NAOVNanoVibronix Inc
14/11/202417:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAOVNanoVibronix Inc
12/11/202410:00Business WireNanoVibronix Provides Business UpdateNASDAQ:NAOVNanoVibronix Inc
29/10/202417:29Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NAOVNanoVibronix Inc
29/10/202417:26Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NAOVNanoVibronix Inc
29/10/202417:18Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NAOVNanoVibronix Inc
11/10/202417:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAOVNanoVibronix Inc
09/10/202409:30Business WireNanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in GermanyNASDAQ:NAOVNanoVibronix Inc
23/09/202409:30Business WireNanoVibronix Signs Letter of Intent with Potential New DistributorNASDAQ:NAOVNanoVibronix Inc
21/08/202409:30Business WireNanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to StockholdersNASDAQ:NAOVNanoVibronix Inc
22/05/202409:30Business WireNanoVibronix Announces Commencement of UroShield Clinical Study at the University of MichiganNASDAQ:NAOVNanoVibronix Inc
16/05/202409:30Business WireNanoVibronix Issues Letter to StockholdersNASDAQ:NAOVNanoVibronix Inc
14/05/202409:30Business WireNanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShieldNASDAQ:NAOVNanoVibronix Inc
01/05/202409:00Business WireNanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract AwardNASDAQ:NAOVNanoVibronix Inc
28/03/202409:30Business WireNanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShieldNASDAQ:NAOVNanoVibronix Inc
26/02/202419:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAOVNanoVibronix Inc
14/02/202417:45Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NAOVNanoVibronix Inc
06/12/202311:00Business WireNanoVibronix Featured in Your Bladder Health MagazineNASDAQ:NAOVNanoVibronix Inc
04/12/202311:00Business WireNanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution OpportunityNASDAQ:NAOVNanoVibronix Inc
28/11/202311:00Business WireNanoVibronix Announces Agreement for Clinical Study of UroShield at the University of MichiganNASDAQ:NAOVNanoVibronix Inc
21/11/202310:30Business WireNanoVibronix Regains Nasdaq ComplianceNASDAQ:NAOVNanoVibronix Inc
14/11/202310:30Business WireNanoVibronix Issues Letter to ShareholdersNASDAQ:NAOVNanoVibronix Inc
07/11/202310:30Business WireNanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1NASDAQ:NAOVNanoVibronix Inc
27/09/202309:00Business WireNanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug TariffNASDAQ:NAOVNanoVibronix Inc
22/09/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NAOVNanoVibronix Inc
21/09/202311:27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:NAOVNanoVibronix Inc
21/09/202311:25Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:NAOVNanoVibronix Inc
13/09/202317:45Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:NAOVNanoVibronix Inc
12/09/202317:15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:NAOVNanoVibronix Inc
06/09/202309:30Business WireNanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual MeetingNASDAQ:NAOVNanoVibronix Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:NAOV

Seu Histórico Recente

BOV
COGN3
COGNA ON
BOV
IBOV
Índice Bovespa
BOV
GFSA3
GAFISA ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
AMER3
Americanas ON
BOV
TELB4
TELEBRAS PN
BOV
AGXY3
Agrogalaxy Participacoes ON
BOV
AMBP3
Ambipar Participacoes e ... ON
BOV
GOLL4
GOL PN
BOV
ATOM3
ATOMPAR ON
BOV
BOBR4
BOMBRIL PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados